Adjuvant therapy provides no additional recurrence-free benefit for esophageal squamous cell carcinoma patients after neoadjuvant chemoimmunotherapy and surgery: a multi-center propensity score match study

PurposeThe need for adjuvant therapy (AT) following neoadjuvant chemoimmunotherapy (nICT) and surgery in esophageal squamous cell cancer (ESCC) remains uncertain. This study aims to investigate whether AT offers additional benefits in terms of recurrence-free survival (RFS) for ESCC patients after n...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Frontiers in Immunology
المؤلفون الرئيسيون:	Shu-Han Xie, Li-Tao Yang, Hai Zhang, Zi-Lu Tang, Zhi-Wei Lin, Yi Chen, Zhi-Nuan Hong, Rong-Yu Xu, Wan-Li Lin, Ming-Qiang Kang
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Frontiers Media S.A. 2024-02-01
الموضوعات:	adjuvant therapy neoadjuvant chemoimmunotherapy esophageal cancer propensity score matching recurrence-free survival
الوصول للمادة أونلاين:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1332492/full

مواد مشابهة

Application of machine learning based on habitat imaging and vision transformer to predict treatment response of locally advanced esophageal squamous cell carcinoma following neoadjuvant chemoimmunotherapy: a multi-center study
حسب: Shu-Han Xie, وآخرون
منشور في: (2025-08-01)

Indocyanine Green Fluorescence Using in Conduit Reconstruction for Patients With Esophageal Cancer to Improve Short-Term Clinical Outcome: A Meta-Analysis
حسب: Zhi-Nuan Hong, وآخرون
منشور في: (2022-06-01)

Editorial: Frontiers' research topic “advances in esophageal cancer surgery with neoadjuvant therapies”
حسب: Qi-Xin Shang, وآخرون
منشور في: (2023-11-01)

The prognostic power of major pathological response in esophageal squamous cell carcinoma patients undergoing neoadjuvant chemoimmunotherapy: a multi-center cohort study
حسب: Shuhan Xie, وآخرون
منشور في: (2025-07-01)

Chemoimmunotherapy as induction treatment in concurrent chemoradiotherapy for patients with nasopharyngeal carcinoma stage IVa
حسب: Kun-Peng Wu, وآخرون
منشور في: (2025-12-01)

Ferritin‐Based Nanocomposite Hydrogel Promotes Tumor Penetration and Enhances Cancer Chemoimmunotherapy
حسب: Rong Liu, وآخرون
منشور في: (2024-01-01)

Comparison of different exercise modalities on fatigue and muscular fitness in patients with multiple sclerosis: a systematic review with network, and dose–response meta-analyses
حسب: Xi-Nuan Zhang, وآخرون
منشور في: (2024-11-01)

Nanoparticle-Mediated Synergistic Chemoimmunotherapy for Cancer Treatment
حسب: Lang X, وآخرون
منشور في: (2024-05-01)

A pH/ROS dual-responsive system for effective chemoimmunotherapy against melanoma via remodeling tumor immune microenvironment
حسب: Leilei Wang, وآخرون
منشور في: (2024-05-01)

Metabolomic machine learning-based model predicts efficacy of chemoimmunotherapy for advanced lung squamous cell carcinoma
حسب: Liang Zheng, وآخرون
منشور في: (2025-04-01)

Association Between Antibiotic and Outcomes of Chemoimmunotherapy for Extensive‐Stage Small Cell Lung Cancer: A Multicenter Retrospective Study of 132 Patients
حسب: Fang Deng, وآخرون
منشور في: (2025-01-01)

Clinical factors and major pathological response after neoadjuvant chemoimmunotherapy in potentially resectable lung squamous cell carcinoma
حسب: Ye Wang, وآخرون
منشور في: (2024-04-01)

Prognostic value of inflammatory nutritional scores in locally advanced esophageal squamous cell carcinoma patients undergoing neoadjuvant chemoimmunotherapy: a multicenter study in China
حسب: Jinxin Xu, وآخرون
منشور في: (2024-02-01)

Impacts of the Major Drought in Chile and Mitigation Measures
حسب: Xu Nuan
منشور في: (2023-01-01)

MRI-based texture analysis for the evaluation of the response to neoadjuvant chemoimmunotherapy in locally advanced head and neck squamous cell carcinoma
حسب: Haoran Wei, وآخرون
منشور في: (2025-07-01)

Intelligent nanovesicle for remodeling tumor microenvironment and circulating tumor chemoimmunotherapy amplification
حسب: Manxiu Huai, وآخرون
منشور في: (2024-05-01)

Crystal structure of (E)-2-((3-fluoropyridin-4-yl)methylene)-7-methoxy-3,4-dihydronaphthalen-1(2H)-one, C17H14FNO2
حسب: Wang Chen, وآخرون
منشور في: (2021-09-01)

In situ chemoimmunotherapy hydrogel elicits immunogenic cell death and evokes efficient antitumor immune response
حسب: Qin Liu, وآخرون
منشور في: (2024-04-01)

Early kinetics of serum amyloid A predict clinical benefit to first-line chemoimmunotherapy and immunotherapy in advanced non-small cell lung cancer: a retrospective analysis
حسب: Wei Du, وآخرون
منشور في: (2025-05-01)

Mature tertiary lymphoid structures linked to HPV status and anti-PD-1 based chemoimmunotherapy response in head and neck squamous cell carcinoma
حسب: Lizao Zhang, وآخرون
منشور في: (2025-12-01)

Neoadjuvant chemoimmunotherapy in locally advanced gastric or gastroesophageal junction adenocarcinoma
حسب: Xiao Liu, وآخرون
منشور في: (2024-04-01)

Gait in depression: a bibliometric analysis and knowledge mapping of research trends over the past 20 years
حسب: Shao-Kui Kan, وآخرون
منشور في: (2025-08-01)

ATF3 Within the Interferon Signaling Pathway: A Potential Biomarker for Predicting Pathological Response to Neoadjuvant Chemoimmunotherapy
حسب: Chao He, وآخرون
منشور في: (2025-04-01)

Neoadjuvant chemoimmunotherapy for locally advanced squamous cell carcinoma of the head and neck: Systematic review and meta-analysis
حسب: Xiayi Zhu, وآخرون
منشور في: (2025-02-01)

Comparison of single-port inflatable mediastinoscopic esophagectomy and thoracoscopic esophagectomy in patients with esophageal squamous cell carcinoma after neoadjuvant chemoimmunotherapy
حسب: Kaishang Zhang, وآخرون
منشور في: (2025-07-01)

Fucoidan-decorated metal-zoledronic acid nanocomplexes suppress tumor metastasis by inducing ferroptotic cell death and enhancing cancer immunotherapy
حسب: Hsin-Ting Tsai, وآخرون
منشور في: (2025-06-01)

The Application of Multimedia Visualization Platform in Business Management from the Perspective of Supply Chain Management
حسب: Nuan Wang
منشور في: (2022-01-01)

The association of serum selenium with serum lipids in US adults
حسب: Wen Nuan
منشور في: (2021-01-01)

Advances in Lipid-Based Nanoparticles for Cancer Chemoimmunotherapy
حسب: Tianqi Wang, وآخرون
منشور في: (2021-04-01)

THE CHEMOIMMUNOTHERAPY BASED ON DENDRITIC CELLS AND CISPLATIN IN EXPERIMENT
حسب: Gorbach O. I., وآخرون
منشور في: (2014-08-01)

Prognostic Impact of Adjuvant Immunotherapy in Patients With Resectable NSCLC After Neoadjuvant Chemoimmunotherapy: A Brief Report
حسب: Yichen Dong, MD, وآخرون
منشور في: (2025-01-01)

Trunk balance, head posture and plantar pressure in adolescent idiopathic scoliosis
حسب: Jin-Xu Wen, وآخرون
منشور في: (2022-10-01)

Case report: Watch-and-wait strategy in resectable esophageal cancer following neoadjuvant chemoimmunotherapy: a case series
حسب: Lingyu Tan, وآخرون
منشور في: (2025-01-01)

Symptomatic Follicular Lymphoma: Complete Remission After Chemoimmunotherapy with Bendamustine–Rituximab
حسب: Wulyo Rajabto, وآخرون
منشور في: (2024-07-01)

Impact of Tregs on tumor regression in locally advanced G/GEJ cancer patients undergoing neoadjuvant chemoimmunotherapy
حسب: Yong Zhang, وآخرون
منشور في: (2025-08-01)

Heterogeneity between subgroups of first-line chemoimmunotherapy for extensive-stage small cell lung cancer patients: a meta-analysis and systematic review
حسب: Wenwen Kang, وآخرون
منشور في: (2024-10-01)

Perioperative or neo/adjuvant chemoimmunotherapy versus chemotherapy for resectable non-small cell lung cancer: a systematic review and network meta-analysis
حسب: Qiong Zhang, وآخرون
منشور في: (2025-01-01)

Traditional Chinese medicine-facilitated redox-labile paclitaxel dimer nanoprodrug for efficient chemoimmunotherapy
حسب: Fan Li, وآخرون
منشور في: (2025-09-01)

A real‐world comparison between neoadjuvant chemoimmunotherapy and chemotherapy alone for resectable non‐small cell lung cancer
حسب: Baihua Zhang, وآخرون
منشور في: (2023-01-01)

Imatinib-induced severe hematological toxicity: Prolonged myelosuppression resulting from extraordinary sensitivity in an old age
حسب: Jia Xu, وآخرون
منشور في: (2023-02-01)